208 related articles for article (PubMed ID: 23186333)
1. Prx I suppresses K-ras-driven lung tumorigenesis by opposing redox-sensitive ERK/cyclin D1 pathway.
Park YH; Kim SU; Lee BK; Kim HS; Song IS; Shin HJ; Han YH; Chang KT; Kim JM; Lee DS; Kim YH; Choi CM; Kim BY; Yu DY
Antioxid Redox Signal; 2013 Aug; 19(5):482-96. PubMed ID: 23186333
[TBL] [Abstract][Full Text] [Related]
2. Peroxiredoxin II promotes hepatic tumorigenesis through cooperation with Ras/Forkhead box M1 signaling pathway.
Park YH; Kim SU; Kwon TH; Kim JM; Song IS; Shin HJ; Lee BK; Bang DH; Lee SJ; Lee DS; Chang KT; Kim BY; Yu DY
Oncogene; 2016 Jul; 35(27):3503-13. PubMed ID: 26500057
[TBL] [Abstract][Full Text] [Related]
3. Peroxiredoxin I is important for cancer-cell survival in Ras-induced hepatic tumorigenesis.
Han B; Shin HJ; Bak IS; Bak Y; Jeong YL; Kwon T; Park YH; Sun HN; Kim CH; Yu DY
Oncotarget; 2016 Oct; 7(42):68044-68056. PubMed ID: 27517622
[TBL] [Abstract][Full Text] [Related]
4. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis.
DeNicola GM; Karreth FA; Humpton TJ; Gopinathan A; Wei C; Frese K; Mangal D; Yu KH; Yeo CJ; Calhoun ES; Scrimieri F; Winter JM; Hruban RH; Iacobuzio-Donahue C; Kern SE; Blair IA; Tuveson DA
Nature; 2011 Jul; 475(7354):106-9. PubMed ID: 21734707
[TBL] [Abstract][Full Text] [Related]
5. The Ras oncogene signals centrosome amplification in mammary epithelial cells through cyclin D1/Cdk4 and Nek2.
Zeng X; Shaikh FY; Harrison MK; Adon AM; Trimboli AJ; Carroll KA; Sharma N; Timmers C; Chodosh LA; Leone G; Saavedra HI
Oncogene; 2010 Sep; 29(36):5103-12. PubMed ID: 20581865
[TBL] [Abstract][Full Text] [Related]
6. Nuclear factor E2-related factor 2 dependent overexpression of sulfiredoxin and peroxiredoxin III in human lung cancer.
Kim YS; Lee HL; Lee KB; Park JH; Chung WY; Lee KS; Sheen SS; Park KJ; Hwang SC
Korean J Intern Med; 2011 Sep; 26(3):304-13. PubMed ID: 22016591
[TBL] [Abstract][Full Text] [Related]
7. Vorinostat synergizes with EGFR inhibitors in NSCLC cells by increasing ROS via up-regulation of the major mitochondrial porin VDAC1 and modulation of the c-Myc-NRF2-KEAP1 pathway.
Leone A; Roca MS; Ciardiello C; Terranova-Barberio M; Vitagliano C; Ciliberto G; Mancini R; Di Gennaro E; Bruzzese F; Budillon A
Free Radic Biol Med; 2015 Dec; 89():287-99. PubMed ID: 26409771
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of peroxiredoxin II (Prx II) on Ras-ERK-NFkappaB pathway in mouse embryonic fibroblast (MEF) senescence.
Han YH; Kwon JH; Yu DY; Moon EY
Free Radic Res; 2006 Nov; 40(11):1182-9. PubMed ID: 17050172
[TBL] [Abstract][Full Text] [Related]
9. Nerve Growth factor regulation of cyclin D1 in PC12 cells through a p21RAS extracellular signal-regulated kinase pathway requires cooperative interactions between Sp1 and nuclear factor-kappaB.
Marampon F; Casimiro MC; Fu M; Powell MJ; Popov VM; Lindsay J; Zani BM; Ciccarelli C; Watanabe G; Lee RJ; Pestell RG
Mol Biol Cell; 2008 Jun; 19(6):2566-78. PubMed ID: 18367547
[TBL] [Abstract][Full Text] [Related]
10. Aurora-A overexpression enhances cell-aggregation of Ha-ras transformants through the MEK/ERK signaling pathway.
Tseng YS; Lee JC; Huang CY; Liu HS
BMC Cancer; 2009 Dec; 9():435. PubMed ID: 20003375
[TBL] [Abstract][Full Text] [Related]
11. Signaling of extracellular inorganic phosphate up-regulates cyclin D1 expression in proliferating chondrocytes via the Na+/Pi cotransporter Pit-1 and Raf/MEK/ERK pathway.
Kimata M; Michigami T; Tachikawa K; Okada T; Koshimizu T; Yamazaki M; Kogo M; Ozono K
Bone; 2010 Nov; 47(5):938-47. PubMed ID: 20709201
[TBL] [Abstract][Full Text] [Related]
12. Roles of the ERK, JNK/AP-1/cyclin D1-CDK4 pathway in silica-induced cell cycle changes in human embryo lung fibroblast cells.
Jia X; Liu B; Shi X; Ye M; Zhang F; Liu H
Cell Biol Int; 2011 Jul; 35(7):697-704. PubMed ID: 21314641
[TBL] [Abstract][Full Text] [Related]
13. Mouse tissues that undergo neoplastic progression after K-Ras activation are distinguished by nuclear translocation of phospho-Erk1/2 and robust tumor suppressor responses.
Parikh N; Shuck RL; Nguyen TA; Herron A; Donehower LA
Mol Cancer Res; 2012 Jun; 10(6):845-55. PubMed ID: 22532587
[TBL] [Abstract][Full Text] [Related]
14. Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo.
Robles AI; Rodriguez-Puebla ML; Glick AB; Trempus C; Hansen L; Sicinski P; Tennant RW; Weinberg RA; Yuspa SH; Conti CJ
Genes Dev; 1998 Aug; 12(16):2469-74. PubMed ID: 9716400
[TBL] [Abstract][Full Text] [Related]
15. Microglial peroxiredoxin V acts as an inducible anti-inflammatory antioxidant through cooperation with redox signaling cascades.
Sun HN; Kim SU; Huang SM; Kim JM; Park YH; Kim SH; Yang HY; Chung KJ; Lee TH; Choi HS; Min JS; Park MK; Kim SK; Lee SR; Chang KT; Lee SH; Yu DY; Lee DS
J Neurochem; 2010 Jul; 114(1):39-50. PubMed ID: 20345759
[TBL] [Abstract][Full Text] [Related]
16. Retinoblastoma protein (pRB) was significantly phosphorylated through a Ras-to-MAPK pathway in mutant K-ras stably transfected human adrenocortical cells.
Chen YF; Chiu HH; Wu CH; Wang JY; Chen FM; Tzou WH; Shin SJ; Lin SR
DNA Cell Biol; 2003 Oct; 22(10):657-64. PubMed ID: 14611687
[TBL] [Abstract][Full Text] [Related]
17. Involvement of ERK-Nrf-2 signaling in ionizing radiation induced cell death in normal and tumor cells.
Patwardhan RS; Checker R; Sharma D; Sandur SK; Sainis KB
PLoS One; 2013; 8(6):e65929. PubMed ID: 23776571
[TBL] [Abstract][Full Text] [Related]
18. GPx3-mediated redox signaling arrests the cell cycle and acts as a tumor suppressor in lung cancer cell lines.
An BC; Choi YD; Oh IJ; Kim JH; Park JI; Lee SW
PLoS One; 2018; 13(9):e0204170. PubMed ID: 30260967
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C isoforms involved in the transcriptional activation of cyclin D1 by transforming Ha-Ras.
Kampfer S; Windegger M; Hochholdinger F; Schwaiger W; Pestell RG; Baier G; Grunicke HH; Uberall F
J Biol Chem; 2001 Nov; 276(46):42834-42. PubMed ID: 11551901
[TBL] [Abstract][Full Text] [Related]
20. Activated K-ras and INK4a/Arf deficiency cooperate during the development of pancreatic cancer by activation of Notch and NF-κB signaling pathways.
Wang Z; Banerjee S; Ahmad A; Li Y; Azmi AS; Gunn JR; Kong D; Bao B; Ali S; Gao J; Mohammad RM; Miele L; Korc M; Sarkar FH
PLoS One; 2011; 6(6):e20537. PubMed ID: 21673986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
